KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Interest Expenses: 2010-2025

Historic Interest Expenses for TherapeuticsMD (TXMD) over the last 6 years, with Sep 2025 value amounting to $3,000.

  • TherapeuticsMD's Interest Expenses changed negligibly% to $3,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $10,000, marking a year-over-year decrease of 91.53%. This contributed to the annual value of $32.9 million for FY2021, which is 15.17% up from last year.
  • Per TherapeuticsMD's latest filing, its Interest Expenses stood at $3,000 for Q3 2025, which was up 50.00% from $2,000 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Interest Expenses ranged from a high of $14.4 million in Q1 2022 and a low of $2,000 during Q1 2025.
  • Over the past 3 years, TherapeuticsMD's median Interest Expenses value was $3,000 (recorded in 2025), while the average stood at $17,857.
  • In the last 5 years, TherapeuticsMD's Interest Expenses soared by 63.32% in 2021 and then slumped by 99.65% in 2023.
  • Over the past 5 years, TherapeuticsMD's Interest Expenses (Quarterly) stood at $7.6 million in 2021, then skyrocketed by 40.92% to $14.4 million in 2022, then slumped by 99.65% to $20,000 in 2023, then slumped by 85.00% to $3,000 in 2024, then remained steady at $3,000 in 2025.
  • Its Interest Expenses was $3,000 in Q3 2025, compared to $2,000 in Q2 2025 and $2,000 in Q1 2025.